Author:
Fisher J F,Carter M J,Parsons J,Rissing J P
Abstract
Moxalactam (LY127935; 6059S), a new broad-spectrum beta-lactam antibiotic, was used successfully with an aminoglycoside in a patient with Serratia marcescens meningitis complicating a neurosurgical procedure. With a bioassay method, peak and trough serum and cerebrospinal; fluid concentrations of moxalactam were determined during therapy. Mean peak and trough serum levels were 100.6 and 35.5 micrograms/ml, respectively. Corresponding mean peak and trough cerebrospinal fluid levels were 12.4 and 10.38 micrograms/ml. Cerebrospinal fluid levels of moxalactam exceeded the minimal bactericidal concentration for the infecting organism by more than 30-fold throughout therapy. No untoward effects of moxalactam were observed. Moxalactam may be a useful agent in the treatment of meningitis due to susceptible gram-negative bacilli.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. In vitro antimicrobial activtty of cefoperazone cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other 14-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including f4-lactamase-producing strains;Baker C. N.;Antimicrob. Agents Chemother.,1980
2. Non-traumatic Gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974;Crane L. R.;Medicine (Baltimore),1978
3. Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis;Humbert G.;Antimicrob. Agents Chemother.,1980
4. Moxalactam (LY127935), a new semisynthetic I-oxa-,t-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin;Jones R. N.;Antimicrob. Agents Chemother.,1980
5. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria;Jorgensen J. H.;Antimicrob. Agents Chemother.,1980
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献